Supraventricular tachycardia after withdrawal of prolonged dexmedetomidine infusion in a paediatric patient without heart disease

被引：1
|
作者：
Flores-Gonzalez, J. Carlos [1 ]
Estalella-Mendoza, Ana [1 ]
Lechuga-Sancho, Alfonso M. [2 ]
Hernandez-Gonzalez, Arturo [1 ]
Rubio-Quinones, Fernando [1 ]
Rodriguez-Campoy, Patricia [1 ]
Saldana-Valderas, Monica [3 ]
机构：
[1] Puerta del Mar Univ Hosp, Pediat Intens Care Unit, Cadiz, Spain
[2] Cadiz Univ, Pediat Mother & Child Hlth & Radiol Dept, Cadiz, Spain
[3] Puerta del Mar Univ Hosp, Clin Farmacol Unit, Pharmacol, Cadiz, Spain
来源：
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS | 2017年 / 42卷 / 05期
关键词：
acute respiratory distress syndrome; children; dexmedetomidine; influenza A; paroxysmal supraventricular tachycardia; withdrawal; CRITICALLY-ILL CHILDREN;
D O I：
10.1111/jcpt.12564
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
What is known and objectiveDexmedetomidine (DEX) has been reported to be safe in paediatric patients. Case descriptionWe present the case of a girl without heart disease admitted at our PICU due to an influenza A acute respiratory distress syndrome, who suffered a paroxysmal supraventricular tachycardia (PSVT) twelve hours after DEX progressive withdrawal was completed. What is new and ConclusionThis is the first report of PSVT as an adverse reaction to DEX in a paediatric patient without heart disease.
引用
收藏
页码：653 / 655
页数：3
相关论文
共 50 条
  • [41] Discontinuation of prolonged infusions of dexmedetomidine in critically ill children with heart disease
    Burbano, Nelson H.
    Otero, Andrea V.
    Berry, Donald E.
    Orr, Richard A.
    Munoz, Ricardo A.
    INTENSIVE CARE MEDICINE, 2012, 38 (02) : 300 - 307
  • [42] Dexmedetomidine: Applications for the Pediatric Patient With Congenital Heart Disease
    Joseph D. Tobias
    Punkaj Gupta
    Aymen Naguib
    Andrew R. Yates
    Pediatric Cardiology, 2011, 32 : 1075 - 1087
  • [43] Discontinuation of prolonged infusions of dexmedetomidine in critically ill children with heart disease
    Nelson H. Burbano
    Andrea V. Otero
    Donald E. Berry
    Richard A. Orr
    Ricardo A. Munoz
    Intensive Care Medicine, 2012, 38 : 300 - 307
  • [44] Cardiac conduction disturbances and ventricular tachycardia after prolonged propofol infusion in an infant
    Robinson, Joshua D. C.
    Melman, Yonathan
    Walsh, Edward P.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2008, 31 (08): : 1070 - 1073
  • [45] METABOLIC AND HORMONAL DECOMPENSATION AFTER DELIBERATE WITHDRAWAL OF PROLONGED SUBCUTANEOUS INSULIN INFUSION
    PICKUP, JC
    VIBERTI, GC
    BILOUS, RW
    DALTON, N
    BINDER, C
    BLOOM, SR
    ALBERTI, KGMM
    KEEN, H
    DIABETOLOGIA, 1980, 19 (06) : 563 - 563
  • [46] PROLONGED LABETALOL INFUSION FOR MANAGEMENT OF SEVERE HYPERTENSION AND TACHYCARDIA IN A CRITICALLY ILL TRAUMA PATIENT
    GOLDSMITH, TL
    BARKER, DE
    STRODEL, WE
    DICP-THE ANNALS OF PHARMACOTHERAPY, 1990, 24 (03): : 235 - 238
  • [47] Post-operative Non-sustained Ventricular Tachycardia in a COVID-19 Positive Patient After Ketamine and Dexmedetomidine Infusion
    Sharma, Vandana
    Sarwar, Muhammad
    Koleini, Evin
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)
  • [48] Prevention of Opioid Withdrawal Syndrome After Pediatric Heart Transplantation: Usefulness of Dexmedetomidine
    Vega, Laia
    Sanchez-de-Toledo, Joan
    Gran, Ferran
    Ortega, Juan
    Pujol, Montserrat
    Balcells, Joan
    REVISTA ESPANOLA DE CARDIOLOGIA, 2013, 66 (07): : 593 - 595
  • [49] Catheter ablation of supraventricular tachycardia after tricuspid valve surgery in patients with congenital heart disease: A multicenter comparative study
    Moore, Jeremy P.
    Gallotti, Roberto G.
    Chiriac, Anca
    McLeod, Christopher J.
    Stephenson, Elizabeth A.
    Maghrabi, Khadijah
    Fish, Frank A.
    Kilinc, Orhan U.
    Bradley, David
    Krause, Ulrich
    Balaji, Seshadri
    Shannon, Kevin M.
    HEART RHYTHM, 2020, 17 (01) : 58 - 65
  • [50] Ventricular tachycardia—without structural heart disease: History
    Heeger C.-H.
    Tilz R.R.
    Herzschrittmachertherapie + Elektrophysiologie, 2024, 35 (Suppl 1) : 102 - 109
12345